Please login to the form below

Not currently logged in

Cipla aims to get bigger in Africa with Medpro bid

Makes $220m offer for its South African distributor Cipla Medpro

Indian pharma company Cipla has made a $220m offer to take a majority stake in its South African distributor Cipla Medpro.

Cipla has indicated it wants to take a 51 per cent stake in Cipla Medpro, but stressed that the discussions are in the early stages and may not lead to a deal. If it goes through the deal would be the first overseas acquisition for the Indian drugmaker. 

Cipla Medpro says it is the third-biggest pharma manufacturer in South Africa with revenues of R1.1bn ($120m) in the first six months of 2012, a rise of 28 per cent year-on-year which the company said was pegged back by delays in getting registration of new generic drugs.

Despite the fast growth, the South African company has been destabilised of late by the departure last month of CEO Jerome Smith, who founded the company, ahead of a disciplinary hearing at which he was due to respond to "serious allegations" which have never been disclosed publicly.

The Indian company has a 20-year-long marketing and distribution deal with Cipla Medpro but does not currently own any equity in the company, which currently has a market share by value of around 5 per cent in South Africa. 

Cipla Medpro has been trying to expand its product portfolio in over-the-counter and cancer medicines in South Africa, which is the largest pharma market in Africa and estimated to reach a value of $3.6bn this year, according to data from Business Monitor International.

Cipla names new CEO

Meanwhile, Cipla has just appointed Subhanu Saxena as its new chief executive effective February 1 2013. Saxena will join the company from Novartis Pharma AG, where he was in charge of global product strategy and commercialisation.

22nd November 2012

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

The truth is out there: Patients first
Patient centricity, patient focus, patients first – words that are on everyone’s lips these days. But what do they really mean? Where does the patient voice fit in? And what...
mHealth: The revolution will not be digital
Could mHealth, which has been growing exponentially in recent years, be the answer we have been looking for to address our population health challenge? Could mHealth save healthcare?...
Medical information in precision medicine
Global Medical Information Leader James Oughton reveals the top trends in medical information and precision medicine....